IRHYTHM TECHNOLOGIES INC (IRTC) Stock News
NASDAQ:IRTC - Nasdaq - US4500561067 - Common Stock - Currency: USD
IRTC Latest News, Press Relases and Analysis
Which stocks are gapping on Friday?
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.
Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
Top performers last week: PONY, HIMS, ODD, MTSR, CGON, KNSA, KC, FTDR, ATI, PRDO, and IRTC. Have you invested in them?
Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts
iRhythm raises 2025 sales forecast and launches Zio ECG system in Japan as analysts boost ratings and price targets on strong Q1 performance.
Wells Fargo Upgrades iRhythm Technologies Stock, Raises Price Target To $130: Retail’s Thrilled
The firm’s new target on iRhythm implies a 19.7% upside to Thursday’s closing price.
IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of -6.74% and 3.34%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: HIMS
iRhythm (NASDAQ:IRTC) Surprises With Strong Q1, Full-Year Sales Guidance is Optimistic
Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 20.3% year on year to $158.7 million. The company’s full-year revenue guidance of $695 million at the midpoint came in 2% above analysts’ estimates. Its non-GAAP loss of $0.95 per share was 1.5% below analysts’ consensus estimates.
iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection
iRhythm brings AI-powered Zio® ECG Monitoring System to Japan, delivering 14-day continuous heart monitoring amid rising arrhythmia rates....
iRhythmは、日本においてZio ECG記録・解析システムとしてZio®長期連続モニタリング サービスを開始し、AIを活用した不整脈検出の進化を推進します。
日本で「Zio ECG記録・解析システム」として商業的に導入されたiRhythm...
iRhythm Technologies Announces First Quarter 2025 Financial Results
iRhythm Technologies Announces First Quarter 2025 Financial Results
SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating...
iRhythm Earnings: What To Look For From IRTC
Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be reporting results tomorrow afternoon. Here’s what investors should know.
iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference
SAN FRANCISCO, April 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating...
iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring
Data show iRhythm Zio LTCM clinical superiority with higher diagnostic yield, fewer retests, and fewer CV events vs. all other LTCMs products...
The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS
Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS are included in this Analyst Blog.
Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal?
TEM stock rises for three successive days. Should you expect more upside ahead, or is it time to dump Tempus AI?
iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025
iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025
iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025...
iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability
Report highlights progress against key sustainability initiatives that reflect iRhythm’s commitment to delivering better data, better insights, and better health for all
iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability
iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability...
iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection
Two large studies of over one million patients reveal that short-term Holter-duration monitoring frequently misses actionable arrhythmias and that patient-reported symptoms are an unreliable predictor of arrhythmic events
iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection
Two studies of over 1MM Zio LTCM patients reveal that short-term Holter monitoring frequently misses actionable arrhythmias...
Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried
The company is facing a regulatory setback. But one analyst doesn't expect that to impact its upcoming, potential approval.
Mentions: DXCM
iRhythm (NASDAQ:IRTC) Reports Strong Q4, Stock Soars
Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 24% year on year to $164.3 million. The company expects the full year’s revenue to be around $680 million, close to analysts’ estimates. Its non-GAAP profit of $0.01 per share was significantly above analysts’ consensus estimates.